Ameritas Investment Partners, Inc. - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$53,743
+67.6%
3,094
+35.8%
0.00%
+100.0%
Q2 2023$32,074
+30.9%
2,2780.0%0.00%0.0%
Q1 2023$24,511
-23.1%
2,2780.0%0.00%0.0%
Q4 2022$31,892
+10.0%
2,2780.0%0.00%0.0%
Q3 2022$29,000
+31.8%
2,2780.0%0.00%0.0%
Q2 2022$22,000
-4.3%
2,2780.0%0.00%0.0%
Q1 2022$23,000
-14.8%
2,2780.0%0.00%0.0%
Q4 2021$27,000
+3.8%
2,2780.0%0.00%0.0%
Q3 2021$26,000
-18.8%
2,2780.0%0.00%0.0%
Q2 2021$32,000
-23.8%
2,2780.0%0.00%
-50.0%
Q1 2021$42,000
+5.0%
2,2780.0%0.00%0.0%
Q4 2020$40,000
+14.3%
2,2780.0%0.00%0.0%
Q3 2020$35,000
-18.6%
2,278
+35.6%
0.00%0.0%
Q2 2020$43,000
+186.7%
1,680
+72.3%
0.00%
+100.0%
Q1 2020$15,000
+36.4%
9750.0%0.00%
Q4 2019$11,000
+37.5%
9750.0%0.00%
Q3 2019$8,000
-38.5%
9750.0%0.00%
-100.0%
Q2 2019$13,000
+30.0%
975
+82.2%
0.00%
Q1 2019$10,000
-33.3%
5350.0%0.00%
-100.0%
Q4 2018$15,000
+7.1%
5350.0%0.00%0.0%
Q3 2018$14,0005350.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,374,392$36,376,0004.43%
Opaleye Management Inc. 338,000$8,778,0001.72%
Lion Point Capital, LP 495,748$7,594,0001.67%
Fairmount Funds Management LLC 212,746$3,259,0001.38%
Vivo Capital, LLC 1,151,622$17,643,0001.02%
Spearhead Capital Advisors, LLC 270,117$4,138,0000.79%
Integral Health Asset Management, LLC 120,000$1,838,0000.56%
Endurant Capital Management LP 117,480$1,800,0000.53%
SPHERA FUNDS MANAGEMENT LTD. 259,990$3,983,0000.39%
Ikarian Capital, LLC 342,998$5,254,0000.38%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders